港股异动 | 啤酒股普涨 润啤(0291.HK)、青啤(0168.HK)齐创历史新高
格隆汇1月8日丨啤酒股普涨,润啤(0291.HK)涨超5%领涨,盘中高见78.6港元续创历史新高,市值超2400亿港元,该股去年累涨66.4%。青啤(0168.HK)亦涨近4%创历史新高,市值超1200亿港元,该股去年累涨56.88%。花旗近日发表中资消费股报告表示,基于六个因素(包括复苏溢价、以消费者为中心、创新、供应链快速回应能力、盈利复苏确定性、强现金流),挑选出包括华润啤酒等在内的2021年中资内需股的首选。富瑞曾预期润啤等股票将在2月底公布的季检中染蓝,并且没有股份被剔出成分股。同时,该行估计将有2.28亿美元追入华润啤酒。

Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.